In an eerie echo of last year’s national fungal meningitis outbreak, the US Food and Drug Administration warned Friday that an injectable steroid produced by a compounding pharmacy in Tennessee has caused problems for at least seven people.
The patients received doses of methylprednisolone acetate -- the same drug that caused the fatal outbreak last year. Used in treating pain and inflammation, the drug was produced by Main Street Family Pharmacy in Newbern, Tenn.
Five patients in Illinois developed abscesses after receiving the drug, and two more in North Carolina have been affected. The exact cause was still unclear, but at least one case appeared to be a fungal infection, the FDA said.
“Out of an abundance of caution, the FDA recommends that health care providers not administer any products labeled as sterile from Main Street and quarantine them until further guidance is provided,” an agency press release said.
There have been no reports of meningitis or life-threatening infections, the Tennessee Department of Health has said.
You have reached the limit of 5 free articles in a month
Stay informed with unlimited access to Boston’s trusted news source.
- High-quality journalism from the region’s largest newsroom
- Convenient access across all of your devices
- Today’s Headlines daily newsletter
- Subscriber-only access to exclusive offers, events, contests, eBooks, and more
- Less than 25¢ a week